Asia Pacific Arthroscopy Devices Market Size, Share & Industry Trends Analysis Report By Type, By Application (Knee Arthroscopy, Hip Arthroscopy, Shoulder & Elbow Arthroscopy), By Country and Growth Forecast, 2022 - 2028
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Arthroscopy Devices Market
Market Report Description
The Asia Pacific Arthroscopy Devices Market would witness market growth of 7.6% CAGR during the forecast period (2022-2028).
Due to the growing older population, the prevalence of musculoskeletal illnesses such as osteoarthritis and rheumatoid arthritis boosts the demand for arthroscopy procedures. Additionally, the rise in the number of sports injuries necessitating arthroscopic surgery to avoid total joint replacements is propelling the arthroscopy devices market forward. Moreover, arthroscopic implants now hold the majority of the arthroscopy devices market share and are projected to do so for the foreseeable future. This is due to a variety of implant applications with improved designs, such as smart and tailored implants to treat various ailments, and a surge in implant usage in arthroscopic treatments for injured joints.
The most common sports injuries include sprains, fractures, strains, and dislocations. Rest, ice, compression, and elevation are the most common self-treatment recommendations for these injuries (RICE). Depending on the circumstances, an arthroscopy may be advised for significant injuries that require greater attention.
There are various advantages of arthroscopy devices such as rapid recovery time and fewer postoperative problems, which is contributing to the growth of the regional arthroscopy devices market. Furthermore, there are growing FDI prospects in numerous countries across the region.
In China, the market for arthroscopy is being driven by the rising prevalence of arthritis and the expanding amount of joint surgical procedures. Arthritis was prevalent among middle-aged and older persons in China in 2015, at roughly 31.4 percent. According to the Osteoarthritis Research Society International, the prevalence of knee OA was roughly 8.8%, and the overall number of knee OA cases in China was 37,542,017. (OARSI). In addition, China performed roughly 300,000 hip replacement procedures in 2018. According to WHO projections, the proportion of Chinese people aged 65 and up will rise from 12.4 percent in 2010 to 28 percent in 2040. Obesity and arthritis are projected to become more common as the population of the elderly grows.
The China market dominated the Asia Pacific Arthroscopy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,351.7 million by 2028. The Japan market is experiencing a CAGR of 6.9% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 8.2% during (2022 - 2028).
Based on Type, the market is segmented into Arthroscopes, Arthroscopic Implants, Radiofrequency Systems, Fluid Management Systems, Visualization Systems, Powered Shavers, and Others. Based on Application, the market is segmented into Knee Arthroscopy, Hip Arthroscopy, Shoulder & Elbow Arthroscopy, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Scope of the Study
Market Segments Covered in the Report:
- Arthroscopic Implants
- Radiofrequency Systems
- Fluid Management Systems
- Visualization Systems
- Powered Shavers
- Knee Arthroscopy
- Hip Arthroscopy
- Shoulder & Elbow Arthroscopy
- South Korea
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Johnson & Johnson
- Smith & Nephew PLC
- ConMed Corporation
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Karl Storz SE & Co. KG
- Arthrex, Inc.
- Richard Wolf GmbH
- Henke Sass Wolf GmbH
Unique Offerings from KBV Research
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free